1333223-40-7

Upstream product

• 1333224-88-6 2-(4-fluorophenyl)-6-[methyl(methylsulfonyl)amino]-5-phenyl-1-benzofuran-3-carboxylic acid 
• 593-56-6 N-methoxylamine hydrochloride 
• 1333224-85-3 ethyl 6-amino-2-(4-fluorophenyl)-5-phenyl-1-benzofuran-3-carboxylate 
• 1333224-84-2 ethyl 2-(4-fluorophenyl)-6-nitro-5-phenyl-1-benzofuran-3-carboxylate 
• 1333224-87-5 ethyl 2-(4-fluorophenyl)-6-(methyl(methylsulfonyl)amino)-5-phenyl-1-benzofuran-3-carboxylate 
• 1333224-86-4 ethyl 2-(4-fluorophenyl)-6-(methylsulfonylamino)-5-phenyl-1-benzofuran-3-carboxylate 
• 691857-51-9 ethyl 2-(4-fluorophenyl)-6-nitro-5-(trifluoromethylsulfonyloxy)benzofuran-3-carboxylate 
• 98-80-6 phenylboronic acid 

Relevant academic research and scientific papers

INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE

Disclosed are compounds of formula (I) that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infectio

INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE

Compounds of formula I that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infection and for inhibiting HCV viral replication and /or viral production in a cell-based system.